Rachel Burga

Principal Scientist

Rachel Burga is an accomplished professional who holds the position of Principal Scientist at Obsidian Therapeutics, a pioneering biotechnology company focused on developing innovative therapies and technologies for gene and cell therapies. With a profound commitment to advancing scientific research and therapeutic solutions, Rachel plays a pivotal role in shaping the future of gene and cell therapy at Obsidian Therapeutics.

As a Principal Scientist, Rachel Burga's expertise lies in the field of biotechnology and gene therapy. Her responsibilities encompass overseeing and conducting advanced research projects, developing cutting-edge therapeutic technologies, and collaborating with multidisciplinary teams to advance Obsidian Therapeutics' mission.

Talks About
#biomedicalengineering #scientificresearch

Preferred Locations
#NorthAmerica